Posts by: admin

News

During the European Cancer Congress, Vienna, Austria, Genentech announced positive results from two Phase II studies of atezolizumab in patients with advanced non-small cell lung cancer (NSCLC). Atezolizumab was effective in ... Read more

October 2, 2015October 4, 2015

Genentech Presents Positive Results of Atezolizumab in Advanced Bladder Cancer

News

Genentech recently announced results from a Phase II study, IMvigor 210, during the 2015 European Cancer Congress, Vienna, Austria. The trial assessed the use of investigational cancer immunotherapy atezolizumab in individuals with advanced urothelial carcinoma. ... Read more

February 10, 2015February 10, 2015

Cryoablation Combined With Intra-tumoral Injection of Immunotherapeutic Drugs Offers Promising Outcomes

News

According to researchers at Image Guided Cancer Specialists, cryoablation can efficiently treat several types of cancer, destroying tumors from the inside out and resulting in minimal scarring. Importantly, when ... Read more

February 6, 2015

Novel Assay To Identify Effective Immune Therapies In Lung Cancer Patients

News

In a recent study titled “Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer” and published in the Journal of the National Cancer Institute, a research team ... Read more

February 3, 2015February 3, 2015

Immunotherapy Found To Enhance CD4 T Cell Responses In Tumor Microenvironment

News

In a recent study, titled “Cancer Immunotherapy Employing an Innovative Strategy to Enhance CD4+ T Cell Help in the Tumor Microenvironment”, published in PlosOne, a research team from Johns ... Read more

February 2, 2015February 2, 2015

MicroConstants China Gains Global Rights of AA98 Antibody Drug Candidates

News

MicroConstants China Inc., has announced it gained the global rights from the Institute of Biophysics (IBP), Chinese Academy of Sciences (CAS) to develop AA98 antibody drug candidates that can be used ... Read more

January 30, 2015January 30, 2015

Study Identifies Novel PAD4 Inhibitors

News

In a recent study titled “Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation”, published in Nature Chemical Biology, an international team of researchers has ... Read more

January 29, 2015

Researchers Test Deimmunized Biotherapeutic Agents

News

In a recent study titled “Mapping the Pareto Optimal Design Space for a Functionally Deimmunized Biotherapeutic Candidate”, published in PLOS Computational Biology, a research team led by Karl Griswold, ... Read more

January 28, 2015

Novel Protein Fusion Therapy Effective Against Resistant Leukemia

News

In a new study published in the Journal of Clinical Investigation, a research team from the Children’s Hospital Los Angeles (CHLA) designed a new protein-based therapy that may be ... Read more

January 20, 2015

New Imaging Technique Allows Real-Time Tracking Of Immune Cells

News

In a recent study titled “64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET”, published in the Proceedings of the National ... Read more